Clorox (CLX) Misses Q2 EPS by 18c, Guidance Misses Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CLX Hot Sheet
Price: $100.06 +6.67%
Financial Fact:
Discontinued operations: 0
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Discontinued operations: 0
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Clorox (NYSE: CLX) reported Q2 EPS of $0.66, $0.18 worse than the analyst estimate of $0.84. Revenue for the quarter came in at $1.69 billion versus the consensus estimate of $1.66 billion.
GUIDANCE:
Clorox sees FY2022 EPS of $4.25-$4.50, versus the consensus of $5.41.
- Net sales decline of 1% to 4% (organic sales decline of 1% to 4%)
For earnings history and earnings-related data on Clorox (CLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Clorox (CLX) PT Raised to $94 at Morgan Stanley
- Scotts Miracle-Gro (SMG) Tops Q4 EPS by 5c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
